If we did it would be a pretty insignificant amount but a very significant moment.
The US deal with PrismHealthDx which is only exclusive for 1 year was announced on the 28th of May. The Mexican deal with Patia which is exclusive for 3 years was announced on the 18th of June. The subsequent announcement on the 21st of June clarified certain aspects of both deals in that they were expected to generate royalties from all sales within 4 to 6 months. 4 months from the 28th of May is the 28th of September, so it is possible but not that likely.
Additionally the Quarterly report is the Appendix 4C statement of cash flows and even if Proteomics billed PrismHealthDx for September royalties, it would most likely show as a debtor and therefore not in the cash flow yet.
Its like waiting for a kettle to boil, you know its going to happen, it just seems to take so long.
Here's hoping that I am wrong.
PIQ Price at posting:
23.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)